Press Release

A USD5.9 Billion Global Allergy Diagnostics Market to Witness a Steady CAGR of Around 12% During 2025-30

The Global Allergy Diagnostics Market size was valued at around USD 5.9 billion in 2024 and is projected to reach USD 11.56 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 12% during the forecast period, i.e., 2025-30, cites MarkNtel Advisors in the recent research report. A variety of influences are causing shifts in the allergy testing and management sector, driving the expansion of the Global Allergy Diagnostics Market. The advancement of allergy testing devices is a key factor. Improvements in technology along with molecular diagnostics, multiplex assays, and AI-powered systems have enhanced the precision and overall performance of diagnostics while also offering increased comfort and decreased invasiveness. Another significant factor influencing the market is the developing awareness of the dangers related to allergic reactions. Efforts to elevate awareness and train the public have highlighted the importance of figuring out allergic reactions at an early level. Which is urging individuals to quickly seek medical assistance for diagnosis and remedy.

Simultaneously, growing air pollution and environmental elements along with weather changes are exacerbating allergic situations. The Air Quality Index is deteriorating, extensively in countries like; India, Pakistan, and Bangladesh in Asia-Pacific, with AQI readings exceeding 450, 400, and 200 respectively. Increased levels of particulate be counted and different pollutants heightened allergies, underscoring the need for diagnostic offerings. The government’s efforts are growing to elevate awareness about allergic reactions and enhance healthcare infrastructure to improve access to allergy testing, especially in areas with scarce resources.

Numerous prospects are also available in the Global Allergy Diagnostics Market. The main progress observed is the expansion of allergy testing in developing countries. Because of the enhanced availability of healthcare and increased awareness, there is a rising need for allergy testing products and services in areas such as; Asia-Pacific and Latin America.

Furthermore, the rise in demand for personalized medicine offers a new chance for patients to receive tailored treatments based on their specific allergy test results. This pattern is also supported by collaborations between companies providing diagnostics and drug manufacturers, to provide comprehensive testing and treatment options. Another emerging development is the move towards non-invasive testing, such as saliva tests and smart devices, providing painless and convenient alternatives to traditional skin tests. Furthermore, a growing number of multi-allergen tests are being performed due to the desire of patients and healthcare professionals for comprehensive results to better comprehend complex allergies, resulting in more successful treatment strategies, further states the research report, “Global Allergy Diagnostics Market Analysis, 2025”.

Segmentation Analysis:

In Vitro Tests Segment Holds the Largest Market Share

Based on diagnostic test type, the market is further bifurcated into In Vivo Tests and In Vitro Tests. The Blood Test is becoming the preferred option for allergy testing in the in Vitro Test category accounting for almost 65% of the market, due to its precision, safety, and flexibility. More people are turning to precise IgE blood tests for allergy diagnosis because of their non-invasive nature and excessive accuracy. This test is performed in a manner that avoids the possibility of entering touch with substances that might cause damage to individuals with extreme allergies or allergic reactions that might be life-threatening. These assessments determine the levels of IgE antibodies generated in response to allergens, supplying a radical and personalized assessment of allergic reactions.

This is especially advantageous for people who cannot undergo skin tests, such as individuals with severe skin conditions like eczema, young children, or elderly individuals. Additionally, blood tests provide a more thorough analysis than skin testing as they can test for multiple allergens at once. Due to technological progress, point-of-care settings can now perform blood tests, increasing access and convenience.

North America Leads the Allergy Diagnostics Industry

Geographically, North America is leading the Global Allergy Diagnostics Market holding approximately 35% of the market because of its excessive incidence of allergic conditions and superior medical Centers. The robust demand for diagnostic services is similarly supported by the region's well-established healthcare structures, making it simpler to implement cutting-edge diagnostic technologies.

Moreover, North America has the advantage of having leading corporations in the allergy diagnostics industry, these companies are creating an environment conducive to innovation, and using market growth through improvements in technology. The area is likewise seeing elevated awareness among the public when it comes to coping with allergic reactions, along with government projects that assist early detection and treatment. Throughout the projected time frame, North America is identified as the top region in the allergy diagnostics market because of these reasons.

Competitive Landscape

With strategic initiatives such as mergers, collaborations, and acquisitions, the leading market companies, including DASIT Group SPA, bioMérieux, R-Biopharm AG, Thermo Fisher Scientific, Inc., ALK, Omega Diagnostics Group PLC, Lincoln Diagnostics, Inc., Allergy Therapeutics, GSK plc, Merck & Co., Inc., HOB Biotech Group Corp. Ltd., Danaher Corporation, Hycor Biomedical Inc., Siemens Healthineers, Hitachi Chemical Co. Ltd., Aravax, and others are looking forward to strengthening their market positions.

Key Questions Answered in the Research Report

1. What are the industry’s overall statistics or estimates (Overview, Size- By Value, Forecast Numbers, Segmentation, Shares)?
2. What are the trends influencing the current scenario of the market?
3. What key factors would propel and impede the industry across the globe?
4. How has the industry been evolving in terms of geography & service adoption?
5. How has the competition been shaping across various regions?
6. How have buying behavior, customer inclination, and expectations from product manufacturers been evolving during 2020-30?
7. Who are the key competitors, and what strategic partnerships or ventures are they coming up with to stay afloat during the projected time frame?